Case Report: Severe rebound after withdrawal of fingolimod in a patient with neuromyelitis optica spectrum disorder

PURPOSE: Fingolimod, an oral treatment for relapsing-remitting multiple sclerosis (RRMS), has been associated with a significant rebound in disease activity after therapy cessation. We described a patient with neuromyelitis optica spectrum disorder (NMOSD) who was previously diagnosed with RRMS and...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Wei, Chou, Chung-Hsing, Yang, Fu-Chi, Tsai, Chia-Kuang, Lin, Yu-Kai, Sung, Yueh-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140362/
https://www.ncbi.nlm.nih.gov/pubmed/37122715
http://dx.doi.org/10.3389/fimmu.2023.1115120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140362/
https://www.ncbi.nlm.nih.gov/pubmed/37122715
http://dx.doi.org/10.3389/fimmu.2023.1115120

Ejemplares similares